Novo Holdings A/S’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Novo Holdings A/S’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,610,487	Closed	-$167M	–	23
2016 Q3	$167M	Hold	3,610,487	–	–	14.79%	3
2016 Q2	$184M	Sell	3,610,487 -1,300,000	-26%	-$64.6M	19.34%	2
2016 Q1	$208M	Hold	4,910,487	–	–	22.75%	2
2015 Q4	$386M	Hold	4,910,487	–	–	37.06%	1
2015 Q3	$199M	Hold	4,910,487	–	–	20.56%	2
2015 Q2	$256M	Hold	4,910,487	–	–	18.38%	2
2015 Q1	$228M	Sell	4,910,487 -991,332	-17%	-$51.5M	19.43%	2
2014 Q4	$265M	Sell	5,901,819 -995,000	-14%	-$41.8M	21.42%	2
2014 Q3	$268M	Hold	6,896,819	–	–	26.18%	2
2014 Q2	$292M	Hold	6,896,819	–	–	28.86%	2
2014 Q1	$246M	Hold	6,896,819	–	–	30.34%	2
2013 Q4	$223M	Buy	+6,896,819	New	+$205M	32.76%	2

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Novo Holdings A/S's ISEE Position: Q4 2016 in Review

Novo Holdings A/S sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016, closing a stake of 3,610,487 shares — an estimated $167M sold.

Novo Holdings A/S first reported a position in ISEE in Q4 2013 and held it in 12 quarters. The position peaked at $386M in Q4 2015. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

Novo Holdings A/S reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Novo Holdings A/S sold 3,610,487 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $167M.
Novo Holdings A/S first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 12 quarters.
Novo Holdings A/S's IVERIC bio, Inc. Common Stock position peaked at $386M in Q4 2015.
137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on Novo Holdings A/S's 13F filing for Q4 2016, filed 14 Feb 2017.